>
pdufa.bio

Zimberelimab

Updated ยทnext FDA decision on the calendar

Zimberelimab is a Arcus Biosciences, Inc. program. Its next catalyst is a Readout in Oct 2026. Every date links its source.

RCUS catalyst hub

All upcoming FDA decision dates on the 2026 PDUFA calendar

About this program

Sponsor: Arcus Biosciences, Inc. (RCUS). We track 1 catalyst event for this program: 1 upcoming and 0 in the record. A PDUFA date is the FDA's target date to complete review of a marketing application; a readout is the sponsor's expected date for clinical trial results. What a PDUFA date is · why we do not compare trial results across drugs.

Catalyst history

Readout · Oct 2026RCUS

Questions

When is Zimberelimab's next FDA decision or readout?

The next tracked catalyst for Zimberelimab is a Readout in Oct 2026.

What happened at Zimberelimab's most recent FDA decision?

No FDA decision for Zimberelimab is in our archive yet.

Who makes Zimberelimab?

Arcus Biosciences, Inc. (RCUS).

Where does this data come from?

FDA announcements, sponsor press releases and SEC filings; every date on this page links its source.